Yes, the early evidence was very encouraging in terms of a decrease both in blood-borne transmission of diseases and in the cost of treatment of those diseases, particularly hepatitis C, but there are also concerns about HIV/AIDS. The safer tattoo practices pilot project was very encouraging, but the program was cancelled before the evaluation was finalized.
On December 1st, 2016. See this statement in context.